Academic literature on the topic 'Sinopharm'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Sinopharm.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Sinopharm"

1

Moghnieh, Rima, Wajdi Haddad, Nayla Jbeily, et al. "Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization." PLOS ONE 19, no. 9 (2024): e0306457. http://dx.doi.org/10.1371/journal.pone.0306457.

Full text
Abstract:
In this study, we conducted a case-control investigation to assess the immunogenicity and effectiveness of primary and first booster homologous and heterologous COVID-19 vaccination regimens against infection and hospitalization, targeting variants circulating in Lebanon during 2021–2022. The study population comprised active Lebanese military personnel between February 2021 and September 2022. Vaccine effectiveness (VE) against laboratory-confirmed SARS-CoV-2 infection and associated hospitalization was retrospectively determined during different variant-predominant periods using a case-contr
APA, Harvard, Vancouver, ISO, and other styles
2

Qaqish, Arwa, Manal Mohammad Abbas, Mohammad Al-Tamimi, Manal Ahmad Abbas, Mariam Al-Omari, and Rami Alqassieh. "SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals." Vaccines 10, no. 5 (2022): 643. http://dx.doi.org/10.3390/vaccines10050643.

Full text
Abstract:
Comparative studies of SARS-CoV-2 antinucleocapsid (anti-N) antibody response in the context of inactivated virus vaccines versus natural infection are limited. This study aims to determine and compare the anti-N antibody levels in people vaccinated with Sinopharm’s (Wuhan, China) inactivated virus vaccine in comparison with naturally infected unvaccinated and Pfizer’s spike (S) mRNA-based vaccinated subjects. Two hundred ninety-nine Jordanian adults participated in the study including unvaccinated COVID-19-infected patients (n = 99), Pfizer-vaccinated (n = 100), and Sinopharm-vaccinated recip
APA, Harvard, Vancouver, ISO, and other styles
3

M Gbaj, Abdul, Emhemmed Ali Elgallal, Inass A Sadawe, et al. "Immunogenicity and Safety of Sinopharm Covid-19 Vaccine in Young Mice." International Journal of Clinical Case Reports and Reviews 10, no. 3 (2022): 01–03. http://dx.doi.org/10.31579/2690-4861/185.

Full text
Abstract:
Background and Aim: Vaccines to prevent SARS-CoV-2 infection may be considered a promising way for reduction of the pandemic. Many different vaccines have become obtainable for use in many countries. The present study aims to evaluate the immune response and the safety of Sinopharm COVID-19 vaccine on 14 days old mice. Materials and Methods:Our experimental study was performed on two weeks old mice, selected by random allocation. The mice were divided into three groups of 12. Group one received asingle dose of 0.5 ml Sinopharm COVID-19 vaccine, group two received two doses of 0.5 ml Sinopharm
APA, Harvard, Vancouver, ISO, and other styles
4

Pareja Cruz, Arturo, Julio César Luque Espino, Nilo Bonifacio Morales, Omar Neyra Colchado, and Joel De León Delgado. "Vacuna Sinopharm… tres años después." Horizonte Médico (Lima) 24, no. 3 (2024): e2390. http://dx.doi.org/10.24265/horizmed.2024.v24n3.00.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sahibzada Syed Masood us Syed, Abid Ali Ranjha, Sidra Ghazanfer, et al. "Prevalence and predictors for adverse effects of Sinopharm and Sinovac COVID-19 Vaccines." Professional Medical Journal 29, no. 11 (2022): 1701–7. http://dx.doi.org/10.29309/tpmj/2022.29.11.7116.

Full text
Abstract:
Objective: To see the prevalence and potential predictors for side effects of Sinopharm and Sinovac COVID-19 vaccines among students of medical, and BS human nutrition and dietetics courses. Study Design: Cross-sectional Proforma-derived. Setting: Sialkot Medical College, Sialkot, Pakistan. Period: July and August, 2021. Material & Methods: Fifty students (MBBS = 30; Dietetics course = 20) with at least one dose of Sinopharm or Sinovac COVID-19 vaccine were recruited, purposively. The subjects were asked to report in an indigenously designed proforma on adverse effects using recall methodo
APA, Harvard, Vancouver, ISO, and other styles
6

Rauf, Muhammad Abdur, Yasir Arafat, Iqtidar-Ud Din, Syed Tahir Shah, Sumia ., and Sajjad Ullah Khan. "Short Terms Safety of Chinese Origin Covid-19 Vaccine in Cardiac Patients." Pakistan Journal of Medical and Health Sciences 16, no. 5 (2022): 1585–87. http://dx.doi.org/10.53350/pjmhs221651585.

Full text
Abstract:
Objective: To find out short terms safety of Chinese origin Covid-19 vaccines in cardiac patients. To identify frequency of major and minor cardiovascular events in Covid-19 vaccinated cardiac patients. Methodology: It was a cross sectional study conducted in Qazi Hussain Ahmad Medical Complex Nowshera and Kuwait Teaching Hospital Peshawar, Pakistan from February 2021 to April 2021 on a sample of 325 cardiac patients irrespective of their gender. Cardiac patients who received 2 doses of sinopharm vaccine were included in our study. The clinical characteristics of patients included age, gender,
APA, Harvard, Vancouver, ISO, and other styles
7

Alqassieh, Rami, Aiman Suleiman, Sami Abu-Halaweh, et al. "Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers." Vaccines 9, no. 11 (2021): 1223. http://dx.doi.org/10.3390/vaccines9111223.

Full text
Abstract:
COVID-19 (coronavirus disease 2019) vaccines induce immunity through different mechanisms. The aim of this study is to compare the titers of specific antibodies in subjects vaccinated with either the Pfizer-BioNTech COVID-19 vaccine or the Sinopharm vaccine. This prospective observational cohort included Jordanian adults vaccinated with two doses, 21 days apart, of either of the two aforementioned vaccines. Titers were collected 6 weeks after the administration of the second dose. Overall, 288 participants were included, of which 141 were administered the Pfizer-BioNTech vaccine, while 147 wer
APA, Harvard, Vancouver, ISO, and other styles
8

Martinez Oliva, Brenda Gisela, Elma Rossell, Denisse Ulloa, Dayana Pamela Bello Kopa, and Ricardo Enrique Grados Torrez. "RESPUESTA INMUNE HUMORAL CONTRA SARS-COV-2 OTORGADA POR SPUTNIK V Y SINOPHARM EN POBLACIÓN BOLIVIANA." Orbis Tertius - UPAL 8, no. 15 (2024): 90–105. http://dx.doi.org/10.59748/ot.v8i15.147.

Full text
Abstract:
Introducción: Las vacunas anti-SARS-CoV-2 inducen la producción de anticuerpos neutralizantes tipo IgG contra el Dominio de Unión al Receptor (RBD) de la proteína S del virus. En Bolivia, las vacunas Sinopharm y Sputnik V fueron ampliamente utilizadas durante la pandemia, sin embargo, existen pocos datos sobre la inmunidad humoral en población boliviana vacunada. Objetivo: Comparar la respuesta humoral conferida contra SARS-CoV-2 por las vacunas Sinopharm y Sputnik V, mediante cuantificación de IgG anti-RBD, producidos por individuos bolivianos, tras 21 días del cumplimiento del esquema comple
APA, Harvard, Vancouver, ISO, and other styles
9

Boshra, Marian S., Raghda R. S. Hussein, Marwa Mohsen, et al. "A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca." Vaccines 10, no. 2 (2022): 292. http://dx.doi.org/10.3390/vaccines10020292.

Full text
Abstract:
Background: Awareness about the COVID-19 vaccine’s adverse effects is crucial for gaining public trust. As we still lack proof of vaccines’ safety, this survey aimed to investigate Egyptians’ general awareness of the Sinopharm and AstraZeneca vaccines against COVID-19 and provide considerable evidence on their side effects and complications. Methods: A cross-sectional questionnaire-based study was conducted in Egypt between 20 September and 10 October in 2021, with multiple-choice questions (MCQs) covering all data on vaccine administration confusion, adverse effects or intensity, and complica
APA, Harvard, Vancouver, ISO, and other styles
10

Meo, Sultan Ayoub, Riham A. ElToukhy, Anusha Sultan Meo, and David C. Klonoff. "Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study." Vaccines 11, no. 4 (2023): 826. http://dx.doi.org/10.3390/vaccines11040826.

Full text
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral zoonotic illness that has developed a distinctive and threatening situation globally. Worldwide, many vaccines were introduced to fight against the COVID-19 pandemic. The present study aims to compare the bio-pharmacological characteristics, indications, contraindications, efficacy, and adverse effects of inactivated whole-virus COVID-19 vaccines, Sinopharm, CoronaVac, and Covaxin. Initially, 262 documents and 6 international organizations were selected. Finally, 41 articles, fact sheets, and international organi
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Sinopharm"

1

Wang, Kuan-Ju, and 王冠茹. "The Study on Integration Strategy of Medical Device Industry in Taiwan – The Case of the Joint Venture Project between Excelsior and Sinopharm." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/63940508988647159237.

Full text
Abstract:
碩士<br>國立中山大學<br>高階經營碩士班<br>100<br>Up to date, the biggest challenge of Taiwan’s medical device industry is that the major market was occupied by international companies which directly hold the research and development, manufacture and selling. In addition, the medical devices have the properties in producing few products with diverse forms, research and development with complicating technology and high threshold in the application of product license. As the domestic market in Taiwan is quite small, small and medium-sized enterprises are the mainscales of Enterprises&apos;&apos; Operating Capac
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Sinopharm"

1

CHEN YOU PING FU QUN. Angelica - Sinopharm must use(Chinese Edition). Shanghai Science and Technology Literature Publishing House, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Sinopharm"

1

Jin, Wang. "China’s COVID-19 Vaccine Diplomacy in the Gulf and Beyond: Efforts and Challenges." In Gulf Studies. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-7796-1_39.

Full text
Abstract:
AbstractThis chapter argues that the COVID-19 vaccine has become an important diplomatic tool to expand China’s influence and set up a positive Chinese image in the Middle East. The study reports three important trends in China’s COVID-19 vaccine diplomacy. It states that China’s vaccine diplomacy toward the Middle East still faces challenges. On the one hand, the effectiveness of China’s vaccine is not widely recognized. Some European and American experts still doubt the effect of China’s vaccine made by Sinovac and Sinopharm. On the other hand, China’s mechanism to constrain COVID-19 by national lockdown and universal vaccination might not be copied in the Middle East.
APA, Harvard, Vancouver, ISO, and other styles
2

Shafiekhani, Mojtaba, Mahtabalsadat Mirjalili, Siavash Gholami, et al. "Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-Term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-28012-2_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Morgan, Pippa. "Market Forces and Commercial Chinese Vaccine Sales." In China's COVID-19 Vaccine Supplies to the Global South. Policy Press, 2022. http://dx.doi.org/10.1332/policypress/9781529226324.003.0004.

Full text
Abstract:
This chapter examines commercial vaccine exports from Chinese manufacturers, which were the majority of Chinese vaccine doses administered abroad during the first half of 2021. It first reviews the histories of the companies involved, including Sinopharm (officially known as China National Pharmaceutical Group Corporation), which is an established central state owned enterprise under the State Owned Assets Supervision and Administration Commission (SASAC), and Sinovac and CanSino, which are both relatively young private firms started by entrepreneurial scientists, and were little known before the pandemic. It then describes how these companies each leveraged state support to quickly develop and bring to market their vaccine candidates. Finally, it maps patterns in Chinese vaccine sales during the initial mass vaccination rollout, which were driven both by standard market forces of supply and demand, and by clinical trial partnerships between manufacturers and host states.
APA, Harvard, Vancouver, ISO, and other styles
4

Mafugu, Tafirenyika. "Potential Therapeutics Pathways in Solving the Challenges of the COVID-19 Pandemic." In Biotechnology to Combat COVID-19 [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96283.

Full text
Abstract:
Millions of lives throughout the globe are under threat due to the COVID-19 pandemic. COVID-19 causes severe respiratory tract infections. In most countries COVID-19 Infections and deaths continue to soar despite the various measures put in place by the World Health Organization. These measures include limited mobility through lock down and banning international travelers. Furthermore, social distancing, wearing masks, frequent hand washing with soap and sanitizing were undertaken to slow down the rate of the virus spread. Only few countries like South Korea have been able to contain the virus to date. Our only hope is in biotechnology which have been used to develop diagnostic kits and more recently approved vaccines: vaccines by Pfizer-BioNTech and Moderna; AstraZeneca and Oxford University vaccine; Sputnik V vaccine; Sinopharm and the Beijing Institute of Biological Products vaccine. However, the vaccines are yet to reach the majority of the world population. Hence, there is need for concerted effort among governments and non-governmental organizations in all nations to develop the necessary infrastructures to step up vaccine production, and procurement as well as vaccination programmes. There is need for continued effort in biotechnology, to develop COVID-19 therapeutic drugs.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Sinopharm"

1

Cheng, Zhangkai, Huimin Huang, Peiyan Zheng, Mingshan Xue, Zhiman Liang, and Baoqing Sun. "Humoral and cellular immunity monitoring of Sinopharm/BBIBP COVID-19 vaccine." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa4385.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sun, Baoqing. "Investigation of antibody levels during three doses of Sinopharm/BBIBP vaccine inoculation." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa4582.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Muslim HANTOOSH, Saad. "THE PREVALENCE OF SIDE-EFFECTS AFTER BNT162B2/PFIZER, AZD1222/ASTRAZENECA, AND BBIBP-CORV/SINOPHARM VACCINES AMONG IRAQI RESIDENTS." In VI.International Scientific Congress of Pure,Applied and Technological Sciences. Rimar Academy, 2022. http://dx.doi.org/10.47832/minarcongress6-23.

Full text
Abstract:
Since the first confirmed COVID-19 case in Iraq in February 2020, Iraq has continued to suffer severe waves of COVID-19 infections and deaths. Three vaccines are available in Iraq namely: BNT162b2/Pfizer–BioNTech (PB), AZD1222/AstraZeneca (AZ), and BBIBP-CorV/Sinopharm (SP). This study investigates the prevalence of side effects after the first and second doses of the three vaccines. A cross-sectional study was carried out from May 1, 2021 to February 15, 2022 in the main vaccination center in Al-Muthanna Province, southern Iraq, during the administration of the second dose of the vaccine. The
APA, Harvard, Vancouver, ISO, and other styles
4

Zhou, Mingyang. "Research on the Risk Management of Pharmaceutical Circulation Enterprises -- Taking Sinopharm Holding Co., Ltd as an Example Based on Data Analysis." In Proceedings of the International Conference on Information Economy, Data Modeling and Cloud Computing, ICIDC 2022, 17-19 June 2022, Qingdao, China. EAI, 2022. http://dx.doi.org/10.4108/eai.17-6-2022.2322884.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bohan, Azhar Jabbar, Alia Essam Mahmood Alubadi, Hind Yousif Khalaf, and Nada Nadhir Basheer. "Evaluation of sCD14 and sCD163 in vaccinated subjects with Pfizer-BioNTech (BNT162b2) or Sinopharm (BBIBP-CorV) COVID-19 vaccine in Iraq." In FIFTH INTERNATIONAL CONFERENCE ON APPLIED SCIENCES: ICAS2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0209763.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bohan, Azhar Jabbar, Alia Essam Mahmood Alubadi, and Muna Abdulrahman Hasan. "Correlation between D. Dimer, ferritin and IL-6 levels in vaccinated people by Pfizer-BioNTech (BNT162b2) or Sinopharm (BBIBP-CorV) COVID-19 vaccine." In FIFTH INTERNATIONAL CONFERENCE ON APPLIED SCIENCES: ICAS2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0209764.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"What factors are related to practicing COVID-19 vaccine by population at Ghawr Al-Safi, Jordan." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/yrrz1540.

Full text
Abstract:
Background: COVID-19 vaccines have been offered in Jordan since early march 2021, to all governates around Jordan, in three types: (Pfizer, Sinopharm, and Astrazeneca). However, some populations weren’t vaccinated yet. Several factors maybe related to not practicing the vaccine by the population such as: knowledge, attitude, practice and accessibility of health care, particularly in areas with low socio-economic status. Therefore, studying factors affecting the approach towards vaccination is crucial to improve vaccination rates. Objective: To evaluate and assess the knowledge, attitude, and p
APA, Harvard, Vancouver, ISO, and other styles
8

Lima, Maríllia Raphaella Cabral Fonseca de, Guilherme Antonio de Souza Silva, Leonardo Carvalho de Oliveira Cruz, et al. "MECANISMO DE AÇÃO DAS VARIANTES DE PREOCUPAÇÃO DO SARS-COV-2 E PERFIL DE COBERTURA VACINAL NA PANDEMIA DE COVID-19." In XXVII Semana de Biomedicina Inovação e Ciência. Editora IME, 2021. http://dx.doi.org/10.51161/9786588884119/23.

Full text
Abstract:
Introdução: Variantes virais surgem quando os vírus sofrem mutações genéticas. Para o SARS-CoV-2, as principais variantes de preocupação são Alfa (B.1.1.7), Beta (B.1.351), Gama (P1) e Delta (B.1.617.2), descobertas no Reino Unido, África do Sul, Brasil e Índia, respectivamente. Elas apresentam mutações no gene codificador da proteína S, aumentando a afinidade do vírus pelo receptor ECA2 e diminuindo a ação de anticorpos neutralizantes.¹ Objetivos: Descrever o impacto epidemiológico das variantes do SARS-CoV-2 na pandemia de COVID-19 e sua cobertura vacinal. Métodos: Selecionamos artigos dispo
APA, Harvard, Vancouver, ISO, and other styles
9

Oliveira, YG, EA Moura, MM Montenegro, et al. "IMPORTANCE OF MOLECULAR DIAGNOSIS IN CASES OF MOSAICISM: A CASE WITH MOSAICISM PIGMENTARY AND PRADERWILLI SYNDROME." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.6502.

Full text
Abstract:
Objective: Mosaicism is a usual event in the world population, defined by the presence of two or more genetically different cell lines in the same individual, arising from the same zygote. However, the characterization of mosaicism still poses a great challenge for laboratorial medicine, since variants may not be present in all tissues. This is associated with mosaicism confined to tissue or pigmentary mosaicism, which constitutes a heterogeneous group of skin pigmentation alterations associated with multisystem involvement. Method: We present a case of a three year-old male infant, born from
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!